胃內球囊全球市場報告：趨勢、預測與競爭分析（至 2031 年）

全球胃內球囊市場前景光明，醫院、診所和門診手術中心市場都存在機會。預計到 2031 年全球胃內球囊市場規模將達到 1.753 億美元，2025-2031 年期間的複合年成長率為 10.7%。這個市場的主要驅動力是肥胖症盛行率的上升、對非手術減重選擇的認知的提高以及對減重治療的認知的提高。

• Lucintel 預測，在預測期內，內視鏡檢查部分將繼續成為基於給藥方法的較大部分。
• 根據最終用途，預計醫院在預測期內仍將是最大的組成部分。
• 根據地區，預計北美在預測期內仍將是最大的地區。

胃內球囊市場的策略性成長機會

近年來，由於全球肥胖症及相關疾病的盛行率不斷上升，胃內球囊市場引起了廣泛關注。胃內球囊，也稱為減重水球，是一種非手術減重方法，即將水球插入胃中以抑制飢餓感並增加飽腹感。由於人們對減重手術益處的認知不斷提高、對微創治療的需求不斷增加以及肥胖盛行率不斷上升等因素，預計該市場將在未來幾年顯著成長。該分析探討了胃內球囊市場的策略性成長機會。

• 擴展到新興市場：胃內球囊市場預計將在中國、印度和巴西等肥胖症盛行率急劇上升的新興市場快速成長。由於患者人數眾多、減重解決方案的滲透率相對較低以及人們對胃內球囊益處的認知不斷提高，這些市場代表著巨大的成長機會。
• 下一代球囊的開發：下一代胃內球囊預計將更加先進，具有智慧感測器、可調容量和更長使用壽命等特點。這些技術創新將提高胃內球囊治療的安全性、有效性和病患體驗，進一步擴大市場。
• 日益關注肥胖和代謝疾病：胃內球囊擴大被用於治療肥胖和代謝疾病，包括第 2 型糖尿病、高血壓和睡眠呼吸中止症。隨著這些疾病變得越來越普遍，對胃內球囊的需求預計會增加，這是一個巨大的成長機會。
• 進軍數位健康與遠端醫療：COVID-19 疫情加速了數位健康和​​遠端醫療解決方案的採用。預計胃內球囊市場將受益於數位平台在患者參與、監測和治療計劃方面的日益普及，從而提高這種治療方案的覆蓋範圍和可及性。
• 聯盟和策略夥伴關係：胃內球囊市場中的公司預計將與醫療機構、研究機構和醫療設備製造商建立策略夥伴關係，以加強其胃內球囊的開發、行銷和供應。

胃內球囊市場對於參與開發、製造和分銷這些設備的公司來說是一個重要的策略性成長機會。由於對微創減重解決方案的需求不斷成長、對胃內球囊益處的認知不斷提高以及肥胖症和相關疾病患病率不斷上升等因素，預計市場將快速成長。適應不斷變化的市場趨勢、投資技術創新並建立策略夥伴關係關係的公司將能夠充分利用這個充滿活力且快速發展的市場中的成長機會。

胃內球囊市場促進因素與挑戰

胃內球囊是一種微創減重裝置，已成為一種流行的肥胖管理解決方案。當氣球插入胃中並充氣時，氣球會在胃中產生空間，讓您感到飽腹並減少食物攝取。全球肥胖症盛行率的上升以及對非手術減重干預措施的日益重視，推動了胃內球囊市場的成長。然而，市場面臨一些可能阻礙其成長軌跡的挑戰。了解市場促進因素和挑戰對於關注不斷發展的肥胖症治療前景的相關人員至關重要。

市場促進因素

1. 肥胖率上升：肥胖及相關健康問題的日益普及推動了對有效體重管理解決方案的需求。世界衛生組織 (WHO) 報告了令人擔憂的肥胖趨勢，這使得胃內球囊成為一種有吸引力的選擇。

2. 微創手術：與傳統的減重手術不同，插入胃內球囊不需要進行手術，從而減少了潛在的併發症和恢復時間，吸引了那些喜歡微創手術的患者。

3.成本效益：胃內球囊通常比手術治療費用低，這使得更廣泛的患者能夠接受，包括那些減重手術保險覆蓋有限的患者。

4. 認知與接受：隨著人們對肥胖及其對健康的影響的認知不斷提高，人們越來越接受包括胃內球囊的替代減重方法。這是由教育宣傳活動和醫生建議所推動的。

5. 技術進步：球囊技術的創新，例如材料和設計的改進，有助於改善患者的治療效果和滿意度，從而推動市場成長。

任務

1. 監管障礙：了解監管環境對於製造商和醫療保健提供者來說是一個挑戰。嚴格的法規和臨床檢驗的需要可能會延遲新產品進入市場。

2. 長期效果有限：雖然胃內球囊對於短期減肥有效，但對長期效果和維持減肥效果的擔憂可能會阻止潛在用戶。

3.併發症與副作用：胃內球囊雖然創傷小，但可能會引起噁心、嘔吐、腹脹風險等併發症。不良的患者體驗會影響市場聲譽和接受度。

由於肥胖率上升、微創手術的吸引力以及技術進步，胃內球囊市場具有巨大的成長潛力。然而，相關人員必須應對複雜的環境，包括監管環境、來自其他減重療法的競爭以及對長期療效和病人安全的擔憂。了解這些動態對於希望在胃內球囊市場中佔有一席之地並滿足有效肥胖管理解決方案迫切需求的醫療保健提供者、製造商和投資者來說至關重要。隨著人們認知的提高和創新解決方案的出現，市場有機會擴大，同時改善患者對抗肥胖的治療效果。

目錄

第1章執行摘要

第2章全球胃內球囊市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球胃內球囊市場趨勢（2019-2024）及預測（2025-2031）
• 全球胃內球囊市場（依給藥方式）
  • 錠劑類型
  • 內視鏡檢查
• 全球胃內球囊市場（依球囊類型）
  • 單身的
  • 雙重的
  • 三倍
• 全球胃內球囊市場（按填充材）
  • 生理食鹽水填充
  • 氣體填充
• 全球胃內球囊市場（依最終用途分類）
  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第4章。各地區市場趨勢及預測分析（2019-2031）

• 全球胃內球囊市場（按地區）
• 北美胃內球囊市場
• 歐洲胃內球囊市場
• 亞太胃內球囊市場
• 世界其他地區胃內球囊市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球胃內球囊市場成長機會（依給藥方式）
  • 全球胃內球囊市場成長機會（依球囊類型）
  • 全球胃內球囊市場按填充材的成長機會
  • 全球胃內球囊市場成長機會（依最終用途分類）
  • 全球胃內球囊市場各區域成長機會
• 全球胃內球囊市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球胃內球囊市場產能擴張
  • 全球胃內球囊市場的併購和合資企業
  • 認證和許可

第7章主要企業簡介

• Apollo Endosurgery
• Obalon Therapeutics
• Allurion Technologies
• Spatz3
• Helioscopie
• Endalis
• MEDSIL

The future of the global intragastric balloon market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global intragastric balloon market is expected to reach an estimated $175.3 million by 2031 with a CAGR of 10.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of obesity, increasing awareness of non-surgical weight loss options, and augmenting awareness of weight loss treatments.

• Lucintel forecasts that, within the administration category, the endoscopy segment will remain a larger segment over the forecast period.
• Within the end use category, hospitals will remain the largest segment over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Intragastric Balloon Market

The intragastric balloon market has seen significant growth in recent years as an increasing number of people seek effective methods for weight management and obesity treatment. This minimally invasive procedure involves placing a deflated balloon into the stomach, where it is then inflated to create a feeling of fullness. This aids in reducing food intake and, consequently, can lead to weight loss. As public awareness of obesity-related health issues rises, coupled with advancements in technology and medical practices, the intragastric balloon market is evolving rapidly. Several emerging trends are shaping the landscape of this market, impacting everything from product development to patient care strategies.

• Technological Advancements: Innovations in balloon technology are enhancing safety and efficacy. Manufacturers are developing balloons with controlled duration of placement, biodegradable materials, and smart technology that can monitor pressure and adjust accordingly. These advancements lead to more customized patient care and improved outcomes.
• Increase in Patient Awareness: Growing awareness of obesity and its related health issues, exacerbated by increased media coverage and educational campaigns, is driving interest in non-surgical weight loss options like intragastric balloons. Patients are becoming more informed and proactive about their health, leading to higher demand.
• Combination Therapies: There is a trend toward combining intragastric balloon therapy with lifestyle adjustments, nutritional counseling, and behavioral therapy. This integrated approach not only improves weight loss outcomes but also supports long-term maintenance, enhancing overall patient satisfaction.
• Expansion in Treatment Populations: Traditionally used for individuals with a BMI over 30, the indications for intragastric balloon use are expanding to include those with lower BMI levels or specific comorbidities, reflecting a broader acceptance of this treatment within the medical community.
• Regulatory Developments: Ongoing changes in regulations surrounding medical devices are influencing the intragastric balloon market. Regulatory bodies are refining approval processes and safety measures, leading to increased scrutiny of products in development but also ensuring higher standards for patient care.

The intragastric balloon market is undergoing a transformative phase driven by technological advancements, heightened awareness among consumers, and evolving treatment protocols. As the medical community embraces this minimally invasive option as a viable solution for obesity management, the market is poised for substantial growth. The integration of comprehensive approaches, regulatory improvements, and telemedicine further underscores the potential for enhanced patient outcomes. As these trends continue to manifest, stakeholders in the intragastric balloon market-ranging from healthcare providers to manufacturers-must adapt to this dynamic environment to successfully meet the needs of an increasingly health-conscious population.

Recent Developments in the Intragastric Balloon Market

The intragastric balloon market has experienced significant growth in recent years as a non-surgical option for weight management and obesity treatment. This device, which is placed in the stomach to promote a feeling of fullness and reduce food intake, has gained popularity due to its minimally invasive nature and favorable risk profile compared to traditional bariatric surgeries. Recent developments in this market have been driven by advancements in technology, evolving clinical evidence, regulatory approvals, and increasing awareness among healthcare providers and patients about obesity and its associated health risks. As a result, the intragastric balloon has become an integral part of weight management protocols, appealing to a diverse demographic looking for effective, temporary solutions to obesity.

• Innovative Device Designs: Recent innovations in intragastric balloon designs have focused on improving patient comfort and efficacy. Newer models include dual and multi-chamber balloons that can be adjusted post-placement for individualized treatment. Some companies have also introduced balloons that can be filled with either saline or air, allowing for greater flexibility in treatment.
• Clinical Evidence and Efficacy Studies: Ongoing research has provided substantial clinical evidence showcasing the effectiveness of intragastric balloons. Recent studies have highlighted impressive weight loss outcomes, particularly when combined with lifestyle modifications and behavioral therapy. The longitudinal data has led to evolving guidelines and increased acceptance among healthcare providers.
• Regulatory Approvals: The intragastric balloon market has benefited from a steady stream of regulatory approvals from organizations like the FDA and EMA for new balloon types and innovations. This regulatory environment fosters innovation and encourages manufacturers to develop next-generation devices that enhance patient experience and safety.
• Market Expansion and Accessibility: As awareness of obesity as a public health issue continues to grow, more clinics and healthcare facilities are incorporating intragastric balloons into their weight management programs. Geographically, markets are expanding in regions such as Asia-Pacific and Latin America, where rising obesity rates demand diverse treatment options.
• Digital Health Integration: The integration of digital health technologies with intragastric balloon programs is an emerging trend. Mobile apps and telehealth services are being leveraged to monitor patient progress, provide real-time support, and promote adherence to dietary and exercise guidelines. This holistic approach enhances treatment outcomes and patient satisfaction.
• Patient Education and Awareness Campaigns: Efforts to educate potential patients and healthcare professionals about the benefits, risks, and procedures associated with intragastric balloons are increasing. These campaigns are instrumental in fostering trust and understanding, ultimately leading to higher adoption rates.

The intragastric balloon market is poised for growth due to recent technological advancements, robust clinical evidence, and a supportive regulatory landscape. With increasing worldwide obesity rates and the demand for effective weight management solutions, intragastric balloons present a viable alternative for many individuals seeking to improve their health and well-being. Ongoing innovations, combined with educational initiatives, are likely to further bolster the market's expansion and ensure that intragastric balloons play a significant role in the future of obesity management strategies. As awareness and acceptance continue to rise, the potential for the intragastric balloon to improve patient outcomes remains promising, paving the way for a healthier future.

Strategic Growth Opportunities for Intragastric Balloon Market

The intragastric balloon market has been gaining significant attention in recent years due to the increasing prevalence of obesity and related disorders worldwide. The intragastric balloon, also known as the weight loss balloon, is a non-surgical weight loss solution that involves the insertion of a balloon into the stomach to reduce hunger and increase feelings of fullness. This market is expected to witness significant growth in the coming years, driven by factors such as increasing awareness about the benefits of weight loss procedures, growing demand for minimally invasive treatments, and the rising prevalence of obesity. In this analysis, we will explore the strategic growth opportunities for the intragastric balloon market.

• Expansion into Emerging Markets: The intragastric balloon market is expected to grow rapidly in emerging markets such as China, India, and Brazil, where the prevalence of obesity is increasing rapidly. These markets offer significant growth opportunities due to the large patient base, relatively low penetration of weight loss solutions, and increasing awareness about the benefits of intragastric balloons.
• Development of Next-Generation Balloons: The next-generation intragastric balloons are expected to be more advanced, with features such as smart sensors, adjustable capacities, and longer lifespan. These innovations will enhance the safety, efficacy, and patient experience of intragastric balloon treatments, further expanding the market.
• Increased Focus on Bariatric and Metabolic Conditions: Intragastric balloons are being increasingly used to treat bariatric and metabolic conditions such as type 2 diabetes, hypertension, and sleep apnea. As the prevalence of these conditions grows, the demand for intragastric balloons is expected to increase, providing a significant growth opportunity.
• Expansion into Digital Health and Telemedicine: The COVID-19 pandemic has accelerated the adoption of digital health and telemedicine solutions. The intragastric balloon market is expected to benefit from the increasing use of digital platforms for patient engagement, monitoring, and treatment planning, enhancing the reach and accessibility of this treatment option.
• Collaborations and Strategic Partnerships: Companies involved in the intragastric balloon market are expected to form strategic partnerships with healthcare organizations, research institutions, and medical device manufacturers to enhance the development, marketing, and delivery of intragastric balloons.

The intragastric balloon market presents significant strategic growth opportunities for companies involved in the development, manufacture, and distribution of these devices. The market is expected to grow rapidly driven by factors such as expanding demand for minimally invasive weight loss solutions, increasing awareness about the benefits of intragastric balloons, and the rising prevalence of obesity and related disorders. Companies that adapt to evolving market trends, invest in innovation, and form strategic partnerships will be well-positioned to capitalize on the growth opportunities in this dynamic and rapidly evolving market.

Intragastric Balloon Market Driver and Challenges

The intragastric balloon is a minimally invasive weight-loss device that has gained popularity as a solution for obesity management. By being inserted into the stomach and inflated, the balloon takes up space, creating a feeling of fullness and reducing food intake. The rising prevalence of obesity globally, combined with an increasing emphasis on non-surgical weight-loss interventions, has spurred growth in the intragastric balloon market. However, the market faces several challenges that could impede its growth trajectory. Understanding the drivers and challenges within this market is crucial for stakeholders looking to navigate the evolving landscape of obesity treatment options.

Market Drivers

1. Rising Obesity Rates: The increasing prevalence of obesity and related health disorders has heightened the demand for effective weight management solutions. The World Health Organization has reported alarming trends in obesity, making intragastric balloons an appealing option.

2. Minimally Invasive Procedure: Unlike traditional bariatric surgeries, the insertion of an intragastric balloon is a non-surgical procedure, which reduces potential complications and recovery time, attracting patients who prefer less invasive options.

3. Cost-Effectiveness: Intragastric balloons are generally less expensive than surgical alternatives, making them accessible to a broader demographic, including those with limited insurance coverage for weight-loss surgeries.

4. Awareness and Acceptance: Growing awareness surrounding obesity and its health implications has led to increased acceptance of alternative weight-loss methods, including intragastric balloons. This can be attributed to educational campaigns and physician recommendations.

5. Technological Advancements: Innovations in balloon technology, such as improved materials and designs, have contributed to better patient outcomes and satisfaction, boosting market growth.

Challenges

1. Regulatory Hurdles: Navigating the regulatory landscape can be challenging for manufacturers and providers. Stringent regulations and the need for clinical validation can delay market entry for new products.

2. Limited Long-Term Efficacy: While intragastric balloons can aid in short-term weight loss, concerns around their long-term effectiveness and maintenance of weight loss can deter potential users.

3. Complications and Side Effects: Although minimally invasive, intragastric balloons can still lead to complications, such as nausea, vomiting, and deflation risks. Negative patient experiences can impact the market's reputation and acceptance.

The intragastric balloon market holds significant potential for growth driven by rising obesity rates, the appeal of minimally invasive procedures, and advancements in technology. However, stakeholders must navigate a complex landscape that includes regulatory challenges, competition from other weight loss interventions, and concerns surrounding long-term efficacy and patient safety. Understanding these dynamics will be critical for healthcare providers, manufacturers, and investors aiming to establish themselves in the intragastric balloon market and address the pressing need for effective obesity management solutions. As awareness continues to grow and innovative solutions emerge, the market has the opportunity to expand while enhancing patient outcomes in the fight against obesity.

List of Intragastric Balloon Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, intragastric balloon companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intragastric balloon companies profiled in this report include-

• Apollo Endosurgery
• Obalon Therapeutics
• Allurion Technologies
• Spatz3
• Helioscopie
• Endalis
• MEDSIL

Intragastric Balloon by Segment

The study includes a forecast for the global intragastric balloon market by the administration, balloon type, filling material, end use, and region.

Intragastric Balloon Market by Administration [Analysis by Value from 2019 to 2031]:

• Pill Form
• Endoscopy

Intragastric Balloon Market by Balloon Type [Analysis by Value from 2019 to 2031]:

• Single
• Dual
• Triple

Intragastric Balloon Market by Filling Material [Analysis by Value from 2019 to 2031]:

• Saline Filled
• Gas Filled

Intragastric Balloon Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Intragastric Balloon Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Intragastric Balloon Market

As obesity rates continue to rise globally, the demand for minimally invasive interventions like the intragastric balloon is expected to grow, driven by increases in healthcare awareness, obesity prevalence, and advancements in medical technology. Countries across different continents are seeing varying levels of acceptance, regulatory developments, and market dynamics for intragastric balloons. Here's an overview of the intragastric balloon market in key countries:

• United States: The U.S. is one of the largest markets for intragastric balloons, primarily due to the high prevalence of obesity, with an estimated 42.4% of adults classified as obese. Patients are increasingly looking for less invasive options compared to traditional weight loss surgeries. The availability of several FDA-approved devices, such as the Orbera and Reshape balloons, is boosting market growth. Moreover, rising awareness regarding healthy lifestyles and growing support from healthcare providers are favorable factors. Nevertheless, challenges such as reimbursement policies and the need for post-procedure lifestyle changes can impact growth.
• China: China has the world's largest population and is experiencing an escalating obesity crisis, particularly among urban populations. The intragastric balloon market in China is characterized by rapid growth as awareness of obesity-related health risks increases. The rise in disposable income and a growing middle class are contributing to the demand for weight loss solutions. Regulatory approval for intragastric devices has been improving, yet there are still hurdles related to regulation compliance and varying awareness among different regions. Collaborations between established medical device companies and local firms may enhance market penetration.
• India: India is witnessing a notable increase in obesity levels, driven by urbanization, lifestyle changes, and dietary shifts. The intragastric balloon market in India is emerging, with a growing acceptance of bariatric procedures. The cost-effectiveness of intragastric balloons compared to surgical alternatives makes it an attractive option for many patients. Additionally, hospitals and clinics are advocating for non-surgical weight loss options, which helps in raising awareness. However, varying healthcare access and socio-economic factors may influence the overall market dynamics.
• Germany: Germany is a key player in the European intragastric balloon market. The country has a strong healthcare system, and there is a high level of public awareness about obesity and its associated risks. The approval of various intragastric balloon products by health authorities and the availability of reimbursement options contribute to market growth. German patients are increasingly seeking minimally invasive weight loss solutions, making the intragastric balloon an appealing choice. Furthermore, ongoing research and clinical trials in Germany are likely to enhance the credibility and acceptance of these devices.
• Japan: Japan faces a rising obesity issue, yet the cultural perceptions around body image can make acceptance of weight loss solutions distinct compared to Western countries. The intragastric balloon market in Japan is growing, although it is still limited relative to the U.S. and Europe. Japanese healthcare providers are cautious, emphasizing the importance of comprehensive lifestyle changes alongside the intervention. The presence of stringent regulatory requirements also impacts market entry for new devices. However, with the increasing focus on preventive healthcare and effective weight management solutions, growth opportunities exist for the intragastric balloon market in Japan.

Features of the Global Intragastric Balloon Market

Market Size Estimates: Intragastric balloon market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Intragastric balloon market size by various segments, such as by administration, balloon type, filling material, end use, and region in terms of value ($M).

Regional Analysis: Intragastric balloon market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different administrations, balloon types, filling materials, end uses, and regions for the intragastric balloon market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intragastric balloon market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the intragastric balloon market by administration (pill form and endoscopy), balloon type (single, dual, and triple), filling material (saline filled and gas filled), end use (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intragastric Balloon Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Intragastric Balloon Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Intragastric Balloon Market by Administration
  • 3.3.1: Pill Form
  • 3.3.2: Endoscopy
• 3.4: Global Intragastric Balloon Market by Balloon Type
  • 3.4.1: Single
  • 3.4.2: Dual
  • 3.4.3: Triple
• 3.5: Global Intragastric Balloon Market by Filling Material
  • 3.5.1: Saline Filled
  • 3.5.2: Gas Filled
• 3.6: Global Intragastric Balloon Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Clinics
  • 3.6.3: Ambulatory Surgical Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Intragastric Balloon Market by Region
• 4.2: North American Intragastric Balloon Market
  • 4.2.1: North American Market by Administration: Pill Form and Endoscopy
  • 4.2.2: North American Market by End Use: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Intragastric Balloon Market
  • 4.3.1: European Market by Administration: Pill Form and Endoscopy
  • 4.3.2: European Market by End Use: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Intragastric Balloon Market
  • 4.4.1: APAC Market by Administration: Pill Form and Endoscopy
  • 4.4.2: APAC Market by End Use: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Intragastric Balloon Market
  • 4.5.1: ROW Market by Administration: Pill Form and Endoscopy
  • 4.5.2: ROW Market by End Use: Hospitals, Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Intragastric Balloon Market by Administration
  • 6.1.2: Growth Opportunities for the Global Intragastric Balloon Market by Balloon Type
  • 6.1.3: Growth Opportunities for the Global Intragastric Balloon Market by Filling Material
  • 6.1.4: Growth Opportunities for the Global Intragastric Balloon Market by End Use
  • 6.1.5: Growth Opportunities for the Global Intragastric Balloon Market by Region
• 6.2: Emerging Trends in the Global Intragastric Balloon Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Intragastric Balloon Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intragastric Balloon Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Apollo Endosurgery
• 7.2: Obalon Therapeutics
• 7.3: Allurion Technologies
• 7.4: Spatz3
• 7.5: Helioscopie
• 7.6: Endalis
• 7.7: MEDSIL